Suppression of ventricular tachycardia with dronedarone: a case report
Mustaphasahim Shaaraoui1, Ronald Freudenberger, Vadim Levin
1Cardiovascular Division, Department of Medicine, Lehigh Valley Hospital, Allentown, Pennsylvania, USA. Mustapha_H.Shaaraoui@lvhn.org
Introduction:
Dronedarone is a multichannel blocker with similar electrophysiological properties to amiodarone. Dronedarone has not been studied in humans as an agent to suppress ventricular arrhythmias.
Methods:
This case report describes the dramatic antiarrhythmic effects of dronedarone in a patient with nonischemic cardiomyopathy and recurrent ventricular tachycardia, which was resistant to multiple antiarrhythmic agents and endocardial catheter ablation.
Results:
Dronedarone was effective in completely suppressing ventricular tachycardia.
Conclusion:
Further research is needed to establish a potential larger role for dronedarone in controlling ventricular arrhythmias in humans.
Related Concept Videos
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Dysrhythmias II: Classification of Tachyarrhythmias
Dysrhythmias VI: Management of Dysrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...


